BEGIN:VCALENDAR
VERSION:2.0
PRODID:talks.ox.ac.uk
BEGIN:VEVENT
SUMMARY:Will I have to mortgage my house? Reflections on gene therapy\, in
 novation\, and inequality in the USA - Eben Kirksey (University of Oxford)
DTSTART;VALUE=DATE-TIME:20230123T160000Z
DTEND;VALUE=DATE-TIME:20230123T171500Z
UID:https://talks.ox.ac.uk/talks/id/36ca3d79-8bcf-489d-be40-f28c015c202e/
DESCRIPTION:The first FDA-approved gene therapy\, Kymriah\, was released t
 o the public in August 2017 with a $475\,000 price tag. With the emergence
  of personalized genetic medicine\, we are entering a new era of profound 
 inequality. This talk explores the stories of children and parents who sig
 ned up for the Kymriah clinical trial before it was approved--risking thei
 r lives and household finances in pursuit of a cancer cure. Issues of race
  and class played out at Penn Medicine\, as researchers explored new horiz
 ons of hope with living cellular therapies.\nSpeakers:\nEben Kirksey (Univ
 ersity of Oxford)
LOCATION:Maison Française d’Oxford\, 2-10 Norham Rd\, Oxford OX2 6SE
TZID:Europe/London
URL:https://talks.ox.ac.uk/talks/id/36ca3d79-8bcf-489d-be40-f28c015c202e/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:Will I have to mortgage my house? Reflections on gene the
 rapy\, innovation\, and inequality in the USA - Eben Kirksey (University o
 f Oxford)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR